Cancer and Blood Diseases Institute

Fig A: This confocal microscope image shows brain cells from adult mice expressing the protein Olig2 (shown in red). Re-searchers at Cincinnati Children’s discovered that inhibiting Olig2 appears to make aggressive, high-grade gliomas significantly more sensitive to treatment.

Cancer and Blood Diseases Institute

View our Cancer and Blood Diseases Institute Featured Research

Bone Marrow Transplant and Immune Deficiency

Vismodegib Shows Promise in Recurrent Medulloblastoma Sonic Hedgehog Subgroup

Experimental Hematology

Two-Step Gene Therapy Shows Early Promise in Treating High-Grade Gliomas

Hematology

Sickle Cell Breakthrough: A Pill to Replace Blood Transfusions

Cancer and Blood Diseases Institute

Click to view members

Division Summary

Research and Training Details

Faculty	81
Joint Appointment Faculty	23
Research Fellows and Post Docs	38
Research Graduate Students	31
Total Annual Grant Award Dollars	$20,055,067
Total Annual Industry Award Dollars	$4,648,174
Total Publications	212

Clinical Activities and Training

Staff Physicians	17
Clinical Fellows	12
Inpatient Encounters	24,356
Outpatient Encounters	30,734

Donate Now